SQUARE Pharmaceuticals Ltd. (SPL) has three GMP compliant production sites. SPL product range covers: tablet, capsule, liquid orals, inhaler, injectable, suppository, topical preparations like powder, cream, ointment etc. All the plants at Dhaka site are built as per the GMP requirements of US-FDA. UNICEF, Copenhagen has approved Solid Dosage plant of Dhaka Site in 2002 for its Global Supply. The Facility is UK-MHRA approved since 2007 and TGA from 2012. Cephalosporin plant at Dhaka site is a standalone, state-of-the-art manufacturing facility and is TGA certified from 2012. Square is the first to introduce 'Modular Aseptic Compact' system to produce recombinant human insulin in Bangladesh. Objective is to manufacture world class insulin preparations at an affordable price.